This compound is primarily utilized in the pharmaceutical industry as a chiral intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a benzenesulfonamide group and an aminoethyl moiety, makes it valuable for developing drugs targeting specific biological pathways. It is often employed in the production of enzyme inhibitors, particularly those involved in treating bacterial infections or inflammatory conditions. Additionally, its chiral nature allows for the creation of enantiomerically pure compounds, which are critical for enhancing drug efficacy and reducing side effects. Researchers also explore its potential in designing novel therapeutic agents for neurological disorders due to its ability to interact with specific receptors in the central nervous system.